ribavirin has been researched along with Anemia, Aplastic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gorczyńska, E; Jarmoliński, T; Kałwak, K; Matkowska-Kocjan, A; Olejnik, I; Rosa, M; Ussowicz, M | 1 |
| D'Angelo, P; Di Marco, F; Farruggia, P; Mosa, C; Trizzino, A | 1 |
| Albandea Moreno, C; Bautista Galán, C; Ruiz Arredondo, J; Serrato, AR | 1 |
| Broquetas, T; Calleja, JL; Campillo, A; Carrión, JA; de la Revilla, J; Forns, X; Lens, S; Londoño, MC; Mariño, Z; Perello, C; Sánchez-Tapias, JM; Urbano-Ispizua, Á | 1 |
| Fujimi, A; Hirayama, Y; Iyama, S; Kohda, K; Kuribayasi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sakamaki, S; Sato, T | 1 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Holder, K; Milligan, DW; Osman, H | 1 |
6 other study(ies) available for ribavirin and Anemia, Aplastic
| Article | Year |
|---|---|
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.
Topics: Anemia, Aplastic; Bone Marrow; Child; COVID-19; COVID-19 Drug Treatment; Female; Hematopoietic Stem Cell Transplantation; Humans; Metapneumovirus; Pneumonia, Viral; Postoperative Period; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; SARS-CoV-2; Transplantation, Homologous | 2021 |
Treatment of human papillomavirus infection with interferon alpha and ribavirin in a patient with acquired aplastic anemia.
Topics: Anemia, Aplastic; CD4-Positive T-Lymphocytes; Condylomata Acuminata; Drug Combinations; Female; Humans; Interferon-alpha; Papillomaviridae; Ribavirin; Treatment Outcome; Young Adult | 2014 |
[Severe bone marrow aplasia due to triple therapy for hepatitis C virus infection: Apropos of a case].
Topics: Anemia, Aplastic; Anti-Bacterial Agents; Antiviral Agents; Blood Component Transfusion; Drug Therapy, Combination; Filgrastim; Folic Acid; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prednisone; Ribavirin; Viremia; Vitamin B 12 | 2015 |
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C.
Topics: Aged; Anemia, Aplastic; Antiviral Agents; Biopsy; Bone Marrow Examination; Drug Therapy, Combination; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Oligopeptides; Pancytopenia; Polyethylene Glycols; Ribavirin; Risk Factors; Severity of Illness Index; Treatment Outcome | 2015 |
[Successful treatment with oral ribavirin of adenovirus-associated hemophagocytic syndrome in a stem cell transplantation recipient].
Topics: Adenoviridae Infections; Administration, Oral; Anemia, Aplastic; Antiviral Agents; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Ribavirin; Treatment Outcome | 2005 |
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Topics: Administration, Oral; Adult; Anemia; Anemia, Aplastic; Antiviral Agents; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Nausea; Parainfluenza Virus 3, Human; Pilot Projects; Pneumonia, Viral; Population Surveillance; Prospective Studies; Respiratory Syncytial Virus Infections; Respirovirus Infections; Ribavirin; Transplantation Conditioning; Treatment Outcome | 2001 |